The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
Open accessAbstract
Tumour-infiltrating immune cells are a source of important prognostic information for patients with resectable colon cancer. We developed a novel immune model based on systematic assessments of the immune landscape inferred from bulk tumor transcriptomes of stage I-III colon cancer patients. The "Cell type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT)" algorithm was used to estimate the fraction of 22 immune cell types from six microarray public datasets. The random forest method and least absolute shrinkage and selection operator model were then used to establish immunoscores for diagnosis and prognosis. By comparing immune cell compositions in samples of 870 colon cancer patients and 70 normal controls, we constructed a diagnostic model, designated the diagnostic immune risk score (dIRS), that showed high specificity and sensitivity in both the training [area under the curve (AUC) = 0.98, p < 0.001] and validation (AUC 0.96, p < 0.001) sets. We also established a prognostic immune risk score (pIRS) that was found to be an independent prognostic factor for relapse-free survival in every series (training: HR 2.23; validation: HR 1.65; entire: HR 2.01; p < 0.001 for all), which showed better prognostic value than TNM stage. In addition, integration of the pIRS with clinical characteristics in a composite nomogram showed improved accuracy of relapse risk prediction, providing a higher net benefit than TNM stage, with well-fitted calibration curves. The proposed dIRS and pIRS models represent promising novel signatures for the diagnosis and prognosis prediction of colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Sterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., & Carpenter, J. R. (2009) · BMJ · doi:10.1136/bmj.b2393 · Cited by 7,299
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
How To Build and Interpret a Nomogram for Cancer Prognosis
Iasonos, A., Schrag, D., Raj, G. V., & Panageas, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9791 · Cited by 3,222
Pagès, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C., Lugli, A., Zlobec, I., Rau, T. T., Berger, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30789-x · Cited by 2,075
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Budczies, J., Klauschen, F., Sinn, B. V., Győrffy, B., Schmitt, W. D., Darb-Esfahani, S., & Denkert, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051862 · Cited by 1,224
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Surgery · doi:10.1002/bjs.9736 · Cited by 889
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Xu, R.-H., Wei, W., Krawczyk, M., Wang, W., Luo, H., Flagg, K., Yi, S., Shi, W., Quan, Q., Li, K., et al. (2017) · Nature Materials · doi:10.1038/nmat4997 · Cited by 862
Time-dependent ROC curve analysis in medical research: current methods and applications
Kamarudin, A. N., Cox, T., & Kolamunnage-Dona, R. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0332-6 · Cited by 838
L1Penalized Estimation in the Cox Proportional Hazards Model
Goeman, J. J. (2010) · Biometrical Journal · doi:10.1002/bimj.200900028 · Cited by 816
Ali, H. R., Chlon, L., Pharoah, P. D. P., Markowetz, F., & Caldas, C. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002194 · Cited by 615
Angell, H., & Galon, J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.004 · Cited by 574
Wang, T.-T., Zhao, Y.-L., Peng, L.-S., Chen, N., Chen, W., Lv, Y.-P., Mao, F.-Y., Zhang, J.-Y., Cheng, P., Teng, Y.-S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313075 · Cited by 509
Self-citationQuantifying tumor-infiltrating immune cells from transcriptomics data
Finotello, F., & Trajanoski, Z. (2018) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-018-2150-z · Cited by 407
Jang, J.-E., Hajdu, C. H., Liot, C., Miller, G., Dustin, M. L., & Bar-Sagi, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.062 · Cited by 372
Gene expression profiles for a prognostic immunoscore in gastric cancer
Zeng, D., Zhou, R., Yu, Y., Luo, Y., Zhang, J., Sun, H., Bin, J., Liao, Y., Rao, J., Zhang, Y., et al. (2018) · British Journal of Surgery · doi:10.1002/bjs.10871 · Cited by 198
Self-citationYothers, G., O'Connell, M. J., Lee, M., Lopatin, M., Clark-Langone, K. M., Millward, C., Paik, S., Sharif, S., Shak, S., & Wolmark, N. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3116 · Cited by 173
Fu, H., Zhu, Y., Wang, Y., Liu, Z., Zhang, J., Xie, H., Fu, Q., Dai, B., Ye, D., & Xu, J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2687 · Cited by 172
Self-citationWilkinson, N. W., Yothers, G., Lopa, S., Costantino, J. P., Petrelli, N. J., & Wolmark, N. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0881-y · Cited by 143
Wang, Y., Lin, H.-C., Huang, M., Shao, Q., Wang, Z.-Q., Wang, F.-H., Yuan, Y., Li, B., Wang, D., Ding, P.-R., et al. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2094-8 · Cited by 84
Zhou, L., Xu, L., Chen, L., Fu, Q., Liu, Z., Chang, Y., Lin, Z., & Xu, J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1293211 · Cited by 60
Perspectives on Current Tumor-Node-Metastasis (TNM) Staging of Cancers of the Colon and Rectum
Hu, H., Krasinskas, A. M., & Willis, J. E. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.05.004 · Cited by 55
Cited by
Recognition of DNA Methylation Molecular Features for Diagnosis and Prognosis in Gastric Cancer
Liu, D., Li, L., Wang, L., Wang, C., Hu, X., Jiang, Q., Wang, X., Xue, G., Liu, Y., & Xue, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.758926 · Cited by 14
Metadata
- Authors
- Zhou, R., Zhang, J., Zeng, D., Sun, H., Rong, X., Shi, M., Bin, J., Liao, Y., & Liao, W.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2018-12-19
- Volume
- 68
- Issue
- 3
- Pages
- 433-442
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2903814629
- Cited by
- 276
- References
- 30
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.